Companies → KWS SAAT SE & Co. KGaA
Save to list
Remove

KWS SAAT SE & Co. KGaA

Germany, Niedersachsen, Einbeck
Description
by AI
KWS SAAT SE & Co. KGaA, Einbeck, takes on the challenge to continuously improve agricultural productivity to sustainably feed a growing population. We are a multinational corporation specializing in breeding, producing, and marketing elite seeds for corn, sugarbeet, cereals, rapeseed, sunflowers, soybeans, and other agricultural crops. Based on more than 160 years of experience and with 4,800 employees around the world, we offer high-yielding, disease-resistant varieties optimally adapted to the soil, climate, and production systems of each region. We strive to provide our customers with superior and reliable solutions so we can all grow more – for a sustainable agriculture and a food-secure world.
Address:

Grimsehlstr. 31 37574

Einbeck

Niedersachsen Germany

Website:
Revenue
Recent news:

Here's Why We Think KWS SAAT SE KGaA (ETR:KWS) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Source: Simply Wall St. Feb 15, 2026

2026 AgTech & Agriculture Outlook: Funding Shifts, M&A, and Policy Challenges

A comprehensive look at the state of agriculture and AgTech in early 2026, covering declining VC funding, a major biologicals acquisition, farmer trade concerns, AI partnerships, and the impactful EU-Mercosur trade agreement.

Source: IndexBox Jan 31, 2026

Returns On Capital Are Showing Encouraging Signs At KWS SAAT SE KGaA (ETR:KWS)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Source: Simply Wall St. Jan 26, 2026

KWS SAAT SE & Co. KGaA's (ETR:KWS) Stock Been Rising: Are Strong Financials Guiding The Market?

KWS SAAT SE KGaA's (ETR:KWS) stock up by 4.4% over the past three months. Since the market usually pay for a company’s...

Source: Simply Wall St. Jan 2, 2026

Insiders were the key beneficiaries as KWS SAAT SE & Co. KGaA's (ETR:KWS) market cap rises to €2.3b

Key Insights KWS SAAT SE KGaA's significant insider ownership suggests inherent interests in company's expansion 54% of...

Source: Simply Wall St. Dec 17, 2025

KWS SAAT SE & Co. KGaA (ETR:KWS) Looks Interesting, And It's About To Pay A Dividend

KWS SAAT SE & Co. KGaA ( ETR:KWS ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is two...

Source: Simply Wall St. Nov 30, 2025

- Delayed Quote - EUR
KWS.VI
65.70 0.00 (0.00%)
At close March 23 06:37 UTC
Candle
Line
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 2.16 B
Enterprise Value: 2.44 B
Trailing P/E: 11.35
Forward P/E: 10.26
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 1.30
Price/Book (mrq): 1.45
Enterprise Value/Revenue: 1.46
Enterprise Value/EBITDA: 11.06
Financial Highlights
Profitability and Income Statement
Profit Margin: 10.82%
Return on Assets (ttm): 6.66%
Return on Equity (ttm): 13.20%
Revenue (ttm): 1.67 B
Net Income Avi to Common (ttm): 190.88 M
Diluted EPS (ttm): 5.79
Balance Sheet and Cash Flow
Total Cash (mrq): 241.10 M
Total Debt/Equity (mrq): 34.90%
Levered Free Cash Flow (ttm): 172.79 M
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.